Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101)

Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201)

(2013) Y-K Kang et al.   BRITISH JOURNAL OF CANCER

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

(2012) Yung-Jue Bang et al.   LANCET

Systematic review of intraperitoneal chemotherapy for gastric cancer

(2011) G. Matharu et al.   BRITISH JOURNAL OF SURGERY

Randomized clinical trial of adjuvant chemotherapy with intraperitoneal and intravenous cisplatin followed by oral fluorouracil (UFT) in serosa-positive gastric cancer versus curative resection alone: final results of the Japan Clinical Oncology Group trial JCOG9206-2

(2011) Isao Miyashiro et al.   Gastric Cancer

Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer

(2011) James J. Biagi et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical Implication of Serosal Change in Pathologic Subserosa-Limited Gastric Cancer

(2011) Joo Mee Kim et al.   WORLD JOURNAL OF SURGERY

Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer

(2010)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prognostic Significance of Intraoperatively Estimated Surgical Stage in Curatively Resected Gastric Cancer Patients

(2009) Sang Eok Lee et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS